Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety and efficacy of solriamfetol in narcolepsy or OSA
NCT02348632Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- May 2015
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
A Phase 3 trial of solriamfetol in narcolepsy, obstructive sleep apnea (OSA), sponsored by Jazz Pharmaceuticals plc. Started May 2015; status: completed.
02
Drugs
solriamfetol
03
Conditions
narcolepsyobstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT02348632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02348632.